CD4 and pituicytoma: The discrepancy between activation markers of CD25 and phospho-STAT5 positivity within CD4+ conventional T cells in PTCy-treated mice may suggest that activation is incomplete or impaired after PTCy, and we are working to better understand this phenomenon in the laboratory.